Skip to main content
€

Or 34,00€ After 66% tax deduction

I make a monthly donation I make an IFI donation
Logo de labels

Our quality approach

A quality management system (QMS) at the heart of Paris Brain Institute's policy and strategy

Last update: 19/11/2026 Reading time: 1min

Quality management is applied in organisations in a variety of fields, with the aim of developing an organisation's practices by formalising them as effectively as possible, in accordance with 7 founding principles:

  • Customer focus ;
  • Management responsibility;
  • Staff involvement ;
  • Process approach ;
  • Improvement;
  • Evidence-based decision-making;
  • Stakeholder relationship management.

 

Since its creation, Paris Brain Institute has been committed to continuous improvement in its operations and to ensuring that its practices comply with regulatory procedures (RGPD, CSP, BPL, BPC, 3Rs rules), ethical standards and the major standards applicable to its field of activity (ISO 9001, NF S96-900, ISO 20387, ISO 26000).

In particular, this approach aims to :

  • Increase the confidence of customers (mainly research teams) and other interested parties (patients, relatives, employees, donors, etc.) in the organisation's ability to deliver the expected products and services that underpin scientific advances;
  • Identifying and meeting both internal and external requirements, to ensure that all available resources (equipment, staff, technology, information, etc.) are allocated and used effectively and efficiently;
  • Guarantee the reproducibility and consistency of operating methods, data and results obtained.


The Institute's quality strategy is based on 3 main principles, inherent to its organisation and the practices of each entity:

Quality management and organisation of the Institute

Quality management and organisation of the Institute

In October 2018, the institute created the ROQ division: Organisation, Quality and Risk Management is responsible for supporting the various platforms, teams and support functions in implementing and maintaining the quality approach in accordance with specific guidelines. The aim of this support is to ensure that all staff integrate a Quality-Risk Management-Compliance approach into the performance of their duties.

 

Our quality approach in figures:

  • 4 certified entities
  • A minimum of 3 audits per year
  • A team of 3 people to develop the quality management system
  • 2 types of certification obtained (ISO 9001 and NF S-96-900)
Maintaining excellence on technology platforms

Maintaining excellence on technology platforms

Paris Brain Institute has been working for many years to harmonise the practices of its scientific, technological and support (organisational and administrative) departments, by ensuring that they comply with best practice in terms of health, safety and the environment, quality of life at work, social responsibility and the requirements of the ISO 9001 international quality management standard.

The service provision activities of the vectorology (ICV Vectorologie / iVector) and genotyping-sequencing (iGenSeq) platforms have been ISO 9001 certified since 2015*.

Label ISO 9001
"Vectorology and sequencing platform service provision activities".

In addition, the activities of the Institute's DNA & Cell Bank (reception, preparation, conservation and provision of biological resources) have been certified since 2009 in accordance with the NF S96-6900 standard for French biological resource centres. As part of its drive to continuously improve and optimise its practices, in 2023 the biobank will be upgrading its system to comply with the international standard ISO 20387, which governs international biobanking activities.

Label NF S96-900
"Receiving, preparing, storing and making available biological resources of human origin".

The iGenSeq platform has been a member of the IBiSA (Infrastructures en Biologie Santé et Agronomie) Scientific Interest Group since 2021, ensuring the quality of its services and promoting the platform on a national scale. In 2021, iGenSeq also joined the France Génomique network, whose ambition is to maintain French research at a high level of competitiveness and performance in the production and analysis of genomic data.

*Excluding the provision of equipment, as well as chapter 8.3, since the platform does not offer the design and development of products and services.

Quality Commitment and Policy Statement

News that might interest you

Un cerveau avec des couleurs
Artificial intelligence and data science: two young international researchers join the Paris Brain Institute
Following a call for applications for junior team leaders in artificial intelligence—which attracted 96 applicants—the Paris Brain Institute has selected two young researchers, Valeria Fascianelli and Jonathan Nicholas, to build their own research...
11.19.2026 Institutional
Des mains qui manipulent
15 ambitious projects from the Paris Brain Institute supported by the ANR
The Paris Brain Institute has just secured 15 grants under the National Research Agency’s (ANR) 2026 General Call for Proposals (AAPG), for a total of 5.5 million euros.
11.06.2026 Institutional
Installation de la Fresque généreuse sur la façade
“Fresque Généreuse”: solidarity takes center stage on the facade of the Paris Brain Institute
On November 2, 2026, to conclude the celebrations marking its 15th anniversary, Serge Weinberg, president of the Paris Brain Institute; Stéphanie Debette, executive director; and Olivier Goy, patron and ambassador of the Institute, unveiled the...
11.06.2026 Events
Maëlys Solal
Maëlys Solal receives the 20th L’Oréal-UNESCO For Women in Science France Award
Maëlys Solal, a postdoctoral researcher in the Aramis team led by Ninon Burgos and Olivier Colliot, has received the 20th L’Oréal-UNESCO For Women in Science France Young Talents Award. The award recognises the excellence of her research at the...
10.08.2026 Institutional
L'équipe Cure-ND4ALS
European CURE-ND alliance launches the CURE-ND4ALS initiative in order to speed up translational research into Charcot’s disease (ALS)
The European CURE-ND alliance has announced the launch of CURE-ND4ALS, an ambitious, patient-focused initiative that seeks to tackle amyotrophic lateral sclerosis (ALS). The program is supported by the Fonds Invincible Été, a philanthropic fund...
05.29.2026 Institutional
Logo Cure-nd
CURE-ND: a structuring European alliance to transform research on neurodegenerative diseases
In an Insight published this Friday, April 17 in The Lancet Neurology, the four partners of the European CURE-ND alliance, including the Institut du Cerveau, present a joint analysis highlighting their shared ambition: to structure an integrated...
04.18.2026 Institutional
See all our news